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Abstract 
 
Background: Anaphylaxis is a potentially fatal condition requiring immediate resuscitation. 
Data regarding the epidemiology of anaphylaxis are limited and inconsistent. A reason for the 
variability was unavailability of a universally acceptable case definition till 2005. We reviewed 
cases using this new definition 
 
Aim: To review the incidence, clinical presentation, cause and outcome of anaphylaxis at a 
tertiary care center in a low income country. 
 
Design: Retrospective, case series  
 
Methods: Chart review of all patients discharged from Aga Khan University Hospital between 
January 1988 - December 2012 (24 years) with anaphylaxis definition as per second National 
Institute of Allergy and Infection disease/Food Allergy and Anaphylaxis Network Symposium  
 
Results: Total of 129 cases were found with mean age of 41.6 years (SD 18.8). Majority of 
patients had cutaneous features (76.7 %), followed by respiratory (68.9 %), cardiac (64.3 %) and 
gastrointestinal (20.9 %) symptoms respectively. About 22.4 % of patients had positive history 
for allergens out of which 31% (n=9) were exposed to the same allergens. The common causes 
identified for anaphylaxis were drugs (60.5 %), food (16.3 %) and intravenous contrast (10.9 %) 
respectively. Only 22.5 % of cases received epinephrine as part of their initial management. In 4 
patients (3.1 %) the cause of death was attributed to anaphylaxis. 
 
Conclusion: Anaphylaxis is a rare but life threatening condition. Though cutaneous features are 
most common, their absence does not exclude the diagnosis. Drugs were the most common cause 
and epinephrine was not commonly used as first line agent for its management. 
 
Key words: Anaphylaxis, Causes, Outcome, Pakistan  
 
Word count: 250 
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Introduction  
Anaphylaxis is a life-threatening medical emergency requiring prompt recognition and 
resuscitation. Data on the epidemiology, incidence and prevalence of anaphylaxis is limited 
globally.
 
Studies have reported variable incidence ranging from 10.5 to 21 cases per 100,000 
person-years.
(1, 2) 
   Studies from Emergency departments showed the incidence of anaphylaxis as 
high as 0.4% in an Italian study 
(3) 
to as low as 0.04% in an English study.
 (4)
 The overall risk of 
death with anaphylaxis has been estimated to be about 1 %. 
(5)
   One of the limitations of these 
studies is non- standardized case definition of anaphylaxis leading to variability in case 
selections and eventually in their outcome. 
Second National Institute of Allergy and Infection disease/Food Allergy and Anaphylaxis 
Network Symposium (NIAID and FAAN) in 2005 defined the criteria for diagnosis of 
anaphylaxis. Their complete definition aims to capture more than 95% of all the clinical cases 
with three diagnostic criteria. (Table 1) Criterion 1 will identify at least 80% of the anaphylaxis 
cases, even if the allergic status of the patient and potential cause of the reaction is unknown, as 
majority of anaphylactic reactions include skin symptoms. Criterion 2 is anaphylaxis which 
requires a known allergic history and a possible exposure that could occur in the absence of 
cutaneous features such as a child with food allergy. Gastrointestinal symptoms are also 
included. Criterion 3 captures the rare patient with an acute hypotensive episode after exposure 
to a known allergen.
(6) 
Our search for studies on anaphylaxis in low and middle income countries (LMIC) revealed only 
few case reports, 
(7-15)
 as there was a scarcity of comprehensive work on the overall diagnosis 
and management of this life threatening condition. In this study we aim to find out the incidence, 
causes, clinical features and outcome of anaphylaxis in a tertiary care hospital of a low income 
country using the new case definition described by NIAID and FAAN. 
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Methods 
This was retrospective case series of all anaphylaxis cases discharged from the Aga Khan 
University Hospital during the 24 years period from January 1988 to December 2012. Aga Khan 
University Hospital is a 570 bedded private, tertiary care university-affiliated teaching hospital in 
Karachi, Pakistan. 
The cases were selected through the hospital information management system using a 
computerized search of all patients with discharge diagnostic codes, as per International 
Classification of Diseases–9
th
 revision–Clinical Modification (ICD-9-CM). Aga Khan University 
Hospital is using ICD-9-CM since 1988 till date. The codes included anaphylaxis, anaphylactic 
reaction, anaphylactic shock specified (995.0) and allergic reaction not otherwise (995.3). Those 
cases that fulfilled the NIAID and FAAN criteria for anaphylaxis were selected for final review. 
The data were collected on a standard questionnaire by a research assistant who was a medical 
graduate and included information on  patient’s demographics, clinical findings, previous history 
of allergy, causative agent (if known), treatment and length of stay in the hospital. These 
variables were then reviewed for inconsistencies by the primary investigator. Data was stored in 
password protected computers after removal of all personal information.  
Descriptive statistics were calculated and results were expressed in either means ± SDs, or 
percentages. IBM SPSS 19 was used to perform the analysis. 
The study was reviewed by the Ethical Review Committee of Aga Khan University Hospital and 
was given an exemption for an ethical approval.  
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 Results 
During the study period there were 1,04,6321 patients admitted and discharged from all causes 
across age groups. A total of 146 cases with discharge diagnostic codes were found, as per 
International Classification of Diseases–9
th
 revision–Clinical Modification (ICD-9-CM), of 
anaphylaxis, anaphylactic reaction, anaphylactic shock and allergic reaction not otherwise 
specified. Out of which 17 charts had insufficient documentation for anaphylaxis to be clearly 
defined as per NIAID and FAAN criteria (described above) and hence were excluded. This left a 
total of 129 cases with an incidence of 0.01%.  
Out of these 129 cases of anaphylaxis, three patients came twice with anaphylaxis. However, 
each episode of anaphylaxis was considered as a separate entity. The mean age of study 
population was 41.62 years (SD, 18.78; range, 1-83 years). Only 16 cases (12.4%) belonged to 
pediatric age group (less than 18 years).  Females outnumbered males by a ratio of 1.35. 
Out of a total of 129 cases, 90 (69.8%) cases presented to the emergency room with anaphylaxis, 
19 (14.7%) cases occurred in medicine department followed by 9 (7%) in radiology department. 
Altogether 47 (36.4%) patients presented with the sole diagnosis of anaphylaxis with no other 
systemic involvement. 
Clinical features 
The most common were cutaneous findings observed in 99 patients (76.7 %) out of which 83 
patients (64.3%) presented with urticaria while 47 patients (36.4 %) had erythema. Respiratory 
abnormality was present in 89 patients (68.9%). In paediatric population, respiratory symptoms 
were more common comprising of 87.5% of the total. Cardiac features were present in 83 
patients (64.3 %), most common of which was hypotension seen in 52 patients (40.3 %). One 
female patient aged 32 years old had ventricular fibrillation after intravenous contrast and later 
died. Vomiting was the most common gastrointestinal symptom found in 17 patients (13.2 %). 
The clinical features of patients presenting with anaphylaxis are shown in Table 2. 
Causative agents 
The causative agent was identified as per history in 115 patients (89.1%). More than half of the 
patients were allergic to drugs n=74(57.4%); followed by food n=21(16.3%) and intravenous 
(IV) contrast n=14 (10.9%). The details of causative agents are shown in Table 3. Most common 
drugs involved were antibiotics (mainly include penicillin and cephalosporin) and Non-steroidal 
anti-inflammatory agents. Interestingly, one of the patients was allergic to Pheniramine (HI 
antagonist) which is used in the management of anaphylaxis. 
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Out of 21 patients who developed anaphylaxis due to food allergy, 3 were known food allergics; 
for e.g. a patient who was allergic to peanuts consumed a peanut containing ice-cream by 
mistake and developed anaphylaxis. 
 There was one patient who died out of 14 patients who developed anaphylaxis secondary to 
intravenous contrast. Interestingly two patients with hydatid cyst developed anaphylaxis, one 
after aspiration and other preoperatively while operating the cyst. 
Altogether 29 (22.4%) patients had a known history of different allergens, out of which 26 (20.1 
%) had drug allergies and 8 (6.2 %) had food allergies. Common drug allergies were related to 
NSAIDS n=10 (7.7%) and antibiotics n=8 (6.2%). Common food allergens were eggs n=3 
(2.3%) and sea food n=2 (1.5%).  
Treatment and outcome 
Majority of the patients n=58 (45%) received a combination of steroid and Histamine HI 
antagonist as the mainstay of their treatment. Epinephrine was used in only 29 patients (22.5%). 
Figure 1 shows bar representation of the treatment data for patients with anaphylaxis 
Median hospital stay of patient was 2 days (range 1-32 days). Around half of the patients (n=61; 
47.3 %) were discharged from the hospital within 24 hours, 8 (6.2%) patients died during the 
hospital course; out of which four cases were attributed to anaphylaxis as mentioned in Table 4.  
The median time after anaphylaxis when the patient sought medical advice or was given 
treatment was 3 hours. The prevalence of asthma in our study population was found to be 10.1 % 
(n=13).  However; we did not specifically record other atopic conditions.  
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Discussion 
According to the best of our knowledge, this is the first reported case series of anaphylaxis using 
the current criteria from a tertiary care centre in Karachi in the last 24 years  
Our study highlighted the mortality rate of 3.1%, which is much higher than findings reported in 
other studies which range from 0.002% 
(16)
 to 0.65%. 
(2)
. Delay in both diagnosis and subsequent 
use of epinephrine or reluctance of physicians to its use might be the factors involved. A history 
of known asthma was recorded in 10.1% of our patients with anaphylaxis which is much lower 
than  atopy rates reported in other studies; 22%, 
(17)
 23% 
(18)
 , 33% 
(2)
 respectively. . Generally, 
patients with Asthma and cardiac disease and those on beta blockers and who receive rapid IV 
allergen have a worse course. Since none of the patients died had asthma, therefore this was not 
the contributory factor in our patients. One patient died after rapid intravenous contrast, as rapid 
IV allergen could cause severe reaction and contribute to mortality. One patient had preexisting 
cardiac disease and was on beta blocker, this could have been the factor leading to mortality. 
 
Moreover, we only found 129 patients in 24 years which could be an underestimation. Since we 
included only inpatient data, patients presented in Emergency department with anaphylaxis who 
were successfully treated and discharged were not included.  Similarly, patients presented as 
dead on arrival in Emergency department or in cardiac arrest who could not be revived were also 
missed. Majority of our patients were females; a finding similar to other studies.  
Overall, 76.7% of our patients with anaphylaxis had cutaneous features; in contrast, some 
authors have reported that all of their patients had cutaneous manifestations.
 (2, 17)
 Patients with 
acute anaphylaxis might indeed present without cutaneous features because of treatment before 
hospital presentation, spontaneous resolution, or complete absence of such signs, particularly in 
those  presenting with the rapid onset of laryngeal edema or circulatory shock; 
(2)
  similar to our 
findings. We found increased respiratory features in paediatric population; a similar finding to a 
study by Braganza et al. 
(19) 
Majority of the causative agents in our setting were drugs (60.5%); a finding similar to Sheikh et 
al 
(20)
 though other authors have recognized an increasing role of food-induced anaphylaxis. 
(17, 21, 
22)
 One of the reasons could be that the patients are already aware of their food allergies and thus 
avoid them. Antibiotics and NSAIDS were causal for most drug induced anaphylaxis which is in 
agreement with recent studies. 
(2, 22, 23)
 Food was the second most common cause that included 
fish, prawn, milk, eggs and peanuts comparable to other studies. 
(14, 23, 24) 
We also encountered 
two cases of anaphylaxis attributed to hydatid cyst as evident in literature. 
(13)
Around one tenth 
of  cases (10.8 % ) in our study had unidentified cause of anaphylaxis ; which is greater than 
5.3% reported by Helbling et al in Switzerland 
(23)
 but much lower than the numbers reported by 
Yocum et al (32%) 
(2)
 and Kemp et al (37%) in United States
 (22)
. 
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A preexisting allergy to the causative agent was known in 7 % of the patients, which is much 
lower than the rate of 23.2%, 
(18)
 and 24% 
(4)
 reported in other ED series in Australia and 
England respectively. However, major concern is the fact that 6 of our patients were already 
known to be allergic to a drug and still were prescribed the same drug by their family 
practitioner. We were unable to determine whether this was due to failure of patient record 
documentation, an inadequate or absent physician inquiry, or simply insufficient importance 
given to the history of allergens. All of these iatrogenic cases were avoidable as they serve to 
emphasize the need for taking a comprehensive allergy history in every ED patient.  
Out of 21 patients who developed anaphylaxis due to food, 3 were already known to be allergic 
to the same food. We think it could be unintentional as generally our food labels are incomplete 
or missing altogether. It also emphasizes the need of teaching patients to avoid allergen 
containing food.  
The use of H1 antihistamines and steroids was far greater than epinephrine which was used in 
only 22.5% of the patients similar to other studies. 
(25, 26)
 One of the reasons could be that in our 
setting epinephrine is available in bedside crash cart and can be given as a verbal order in case of 
emergency and hence documentation might be missing in the medical record of the patient. 
Epinephrine is considered to be the first-line therapy of anaphylaxis and must be used 
appropriately in acute anaphylaxis. 
(4, 27-29)
 Arguments about recommended doses, route, dilution, 
and timing should not obscure epinephrine's vital role. 
(30-32)
 This study found that most of our 
patients who received epinephrine had severe anaphylactic reaction. Some of our patients with 
syncope, dizziness, and altered conscious levels were recovered spontaneously before hospital 
presentation and others with wheeze responded to inhaled β-2 agonists both of which are 
documented in literature. 
(4)
 However, the subjective nature of the symptoms and the likelihood 
of panic or hyperventilation in some patients might have distorted the data. The additional use of 
H2 with H1 antihistamines reflected local ED policy, supported in a randomized controlled trial 
(33)
 but still controversial. 
(27, 28) 
Limitations of our study include a relatively small number of patients, anaphylactic reactions 
from a single institution and the retrospective design which is prone to reporting bias. One more 
limitation to this study could be selection bias since AKUH is a private, fee for service hospital 
catering to only those who can afford it. One of the other limitations of our study was that we 
were only able to retrieve the data of hospitalized patients and unable to identify patients 
managed and discharged from ED thus underestimating the true incidence.  
Lastly, we suggest that an educational program is necessary to increase awareness in high risk 
groups like in patients with severe reaction, unknown causative agent and recurrent attacks.   
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 Conclusion 
Anaphylaxis is a rare but life threatening condition with high mortality rates. Though cutaneous 
features are most common, their absence does not exclude the diagnosis which is based on 
clinical criteria. A detailed history of known allergens is important for physician to avoid 
iatrogenic causes and for giving instructions to patients for future avoidance. Epinephrine is not 
commonly used as first line agent for its management in everyday medical practice and hence 
efforts are needed to educate physicians about its use.  
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Figure Legend 
Figure 1. Bar representation of treatment received by patients with anaphylaxis. 
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Anaphylaxis is highly likely when any one of the following 3 criteria are fulfilled: 
1. Acute onset of an illness (minutes to several hours) with involvement of the skin, 
mucosal tissue, or both (eg, generalized hives, pruritus or flushing, swollen lips-tongue-
uvula). 
AND AT LEAST ONE OF THE FOLLOWING 
a. Respiratory compromise (eg, dyspnoea, wheeze-bronchospasm, stridor, reduced PEF, 
hypoxaemia). 
b. Reduced BP or associated symptoms of end-organ dysfunction (eg, hypotonia [collapse], 
syncope, incontinence). 
2. Two or more of the following that occur rapidly after exposure to a likely allergen for 
that patient (minutes to several hours): 
a. Involvement of the skin-mucosal tissue (eg, generalized hives, itch-flush, swollen lips-
tongue-uvula). 
b. Respiratory compromise (eg, dyspnoea, wheeze-bronchospasm, stridor, reduced PEF, 
hypoxaemia). 
c. Reduced BP or associated symptoms (eg, hypotonia [collapse], syncope, incontinence). 
d. Persistent gastrointestinal symptoms (eg, crampy abdominal pain, vomiting). 
3. Reduced BP after exposure to known allergen for that patient (minutes to several hours): 
a. Infants and children: low systolic BP (age specific) or greater than 30% decrease in 
systolic BP*. 
b. Adults: systolic BP of less than 90 mmHg or greater than 30% decrease from that 
person’s baseline. 
 
Table 1. Definition of anaphylaxis. Clinical Criteria for Diagnosis 
PEF, Peak expiratory flow; BP, blood pressure. *Low systolic blood pressure for children is defined as less than 70 
mmHg from 1 month to 1 year; less than (70 mmHg + [2 x age]) from 1 to 10 years; and less than 90 mmHg from 11 
to 17 years. (28) 
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  No. of patients (%) 
Cutaneous features 
Urticaria 
Angioedema  
Erythema  
Local edema  
Conjunctivitis  
 
83 (64.3) 
47 (36.4) 
38 (29.5) 
9 (6.9) 
2 (1.5) 
Respiratory features  
Dyspnea 
Wheeze/ Bronchospasm 
Hoarseness 
Stridor 
Gasping  
 
79 (61.2) 
21 (16.2) 
2 (1.5) 
1 (0.8) 
1 (0.8) 
Cardiovascular features 
Hypotension 
Tachycardia 
Syncope/ LOC 
Crepitation 
Cyanosis   
Bradycardia 
Ventricular Fibrillation 
 
52 (40.3) 
26 (20.1) 
24 (18.6) 
4 (3.1) 
4 (3.1) 
3 (2.3) 
1 (0.8) 
Gastrointestinal features  
Vomiting 
Abdominal pain 
Diarrhea 
Tongue swelling 
 
17 (13.2) 
11 (8.5) 
6 (4.6) 
1 (0.8) 
 
Table 2. Clinical features of patients presenting with anaphylaxis 
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Causative agent No. of patients (%) 
Drugs 
Antibiotics 
Penicillin  
Cephalosporin  
Other Antibiotics 
NSAIDS 
Diclofenac  
Dispirin  
Other NSAIDS 
Paracetamol  
HI antagonist  
Other drugs  
78 (60.5) 
22 (17) 
10 (7.8) 
6 (4.7) 
6 (4.7) 
21 (16.3) 
7 (5.4) 
5 (3.9) 
9(7) 
1 (0.8) 
1 (0.8) 
33 (25.6) 
Food  
Dry fruits (peanut etc ) 
Sea food (prawn, shrimps, lobsters  etc) 
Egg  
Beef/ chicken  
Others (burger, haleem, cake etc ) 
21 (16.3) 
2 (1.6) 
9 (7) 
1 (0.8) 
4 (3.1) 
5 (3.9) 
Intravenous contrast  14 (10.9) 
Blood and blood products 3 (2.3) 
Sting/bites  2 (1.6) 
Others 
Anti-lice Shampoo 
Hydatid cyst  
3 (2.3) 
1 (0.8) 
2 (1.6) 
 
Table 3. Causative agent in patients with anaphylaxis 
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Table 4. Details of patients expired due to anaphylaxis. 
 
 
 
 
Age  Sex  Symptoms Presumed 
cause 
Risk 
Factors 
Associated 
diagnosis 
Treatment 
32 Female Tachypnea, 
hypotension, 
ventricular 
fibrillation 
Intravenous 
contrast for 
CT Scan 
Rapid 
intravenous 
contrast 
Renal calculi Epinephrine  
37 Female Stridor, 
hypotension, 
tachycardia, 
urticaria, 
angioedema 
Hakimi 
medications 
Composition?? 
Nil  Interstitial 
nephritis 
secondary to 
Hakimi 
drugs 
Steroid  
60 Male  Wheeze, 
Hypertension, 
tachycardia, 
hemoptysis 
Multivitamin  Cardiac 
patient on 
beta 
blocker 
Disseminated 
intravascular 
coagulation 
Epinephrine, 
Steroid, 
Histamine 
H1 
antagonist,   
Histamine 
H2 
antagonist, 
Inhaled Beta 
2 agonist  
83 Male  Dyspnea, 
hypertension, 
tachycardia, 
urticaria, 
diarrhea, 
seizures, loss 
of 
consciousness  
Ceftriaxone  Nil  Cortical 
venous 
thrombosis 
Epinephrine, 
Steroid, 
Histamine 
H1 
antagonist  
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Bar representation of treatment received by patients with anaphylaxis  
177x127mm (300 x 300 DPI)  
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